Citigroup’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,204
| Closed | -$87K | – | 6913 |
|
|
2021
Q4 | $87K | Sell |
28,204
-7,193
| -20% | -$24.2K | ﹤0.01% | 4806 |
|
|
2021
Q3 | $128K | Buy |
35,397
+11,402
| +48% | +$43K | ﹤0.01% | 4321 |
|
|
2021
Q2 | $86K | Sell |
23,995
-66,084
| -73% | -$233K | ﹤0.01% | 4578 |
|
|
2021
Q1 | $353K | Buy |
90,079
+57,946
| +180% | +$239K | ﹤0.01% | 3695 |
|
|
2020
Q4 | $135K | Buy |
32,133
+13,429
| +72% | +$51.8K | ﹤0.01% | 5292 |
|
|
2020
Q3 | $70K | Sell |
18,704
-25,690
| -58% | -$109K | ﹤0.01% | 5368 |
|
|
2020
Q2 | $194K | Buy |
44,394
+2,329
| +6% | +$10.5K | ﹤0.01% | 5035 |
|
|
2020
Q1 | $160K | Buy |
42,065
+14,382
| +52% | +$70.7K | ﹤0.01% | 4928 |
|
|
2019
Q4 | $175K | Buy |
27,683
+23,539
| +568% | +$138K | ﹤0.01% | 5297 |
|
|
2019
Q3 | $18K | Sell |
4,144
-19,403
| -82% | -$82.9K | ﹤0.01% | 6812 |
|
|
2019
Q2 | $110K | Sell |
23,547
-89,129
| -79% | -$415K | ﹤0.01% | 5781 |
|
|
2019
Q1 | $597K | Buy |
112,676
+111,676
| +11,168% | +$510K | ﹤0.01% | 3992 |
|
|
2018
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 7438 |
|
|
2018
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 7589 |
|
|
2018
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 7450 |
|
|
2018
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 7413 |
|
|
2017
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 7366 |
|
|
2017
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 7001 |
|
|
2017
Q2 | $3K | Sell |
1,000
-5
| -0.5% | -$11 | ﹤0.01% | 6949 |
|
|
2017
Q1 | $2K | Hold |
1,005
| – | – | ﹤0.01% | 7054 |
|
|
2016
Q4 | $2K | Hold |
1,005
| – | – | ﹤0.01% | 7094 |
|
|
2016
Q3 | $3K | Sell |
1,005
-1,081
| -52% | -$2.75K | ﹤0.01% | 6907 |
|
|
2016
Q2 | $5K | Sell |
2,086
-37,603
| -95% | -$104K | ﹤0.01% | 6805 |
|
|
2016
Q1 | $128K | Buy |
39,689
+27,097
| +215% | +$100K | ﹤0.01% | 5488 |
|
|
2015
Q4 | $60K | Sell |
12,592
-65
| -0.5% | -$368 | ﹤0.01% | 5792 |
|
|
2015
Q3 | $71K | Sell |
12,657
-1,145
| -8% | -$8.45K | ﹤0.01% | 5208 |
|
|
2015
Q2 | $111K | Sell |
13,802
-36
| -0.3% | -$309 | ﹤0.01% | 4913 |
|
|
2015
Q1 | $144K | Buy |
13,838
+2,811
| +25% | +$38.4K | ﹤0.01% | 4778 |
|
|
2014
Q4 | $132K | Buy |
11,027
+6,768
| +159% | +$103K | ﹤0.01% | 5024 |
|
|
2014
Q3 | $73K | Buy |
4,259
+67
| +2% | +$972 | ﹤0.01% | 5027 |
|
|
2014
Q2 | $51K | Sell |
4,192
-3,719
| -47% | -$35.3K | ﹤0.01% | 5165 |
|
|
2014
Q1 | $67K | Sell |
7,911
-3,612
| -31% | -$29.1K | ﹤0.01% | 5300 |
|
|
2013
Q4 | $68K | Buy |
11,523
+11,385
| +8,250% | +$58.7K | ﹤0.01% | 5543 |
|
|
2013
Q3 | $1K | Buy |
138
+99
| +254% | +$476 | ﹤0.01% | 6766 |
|
|
2013
Q2 | $0 | Buy |
+39
| New | +$183 | ﹤0.01% | 6903 |
|
Other funds holding BDSI
Citigroup's BDSI Position: Q1 2022 in Review
Citigroup sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 28,204 shares — an estimated $87K sold.
Citigroup first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $597K in Q1 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Citigroup reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Citigroup sold 28,204 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $87K.
- Citigroup first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
- Citigroup's BioDelivery Sciences International, Inc. position peaked at $597K in Q1 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.